View More
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
From Clinical Care Options (CCO), video featuring expert presentations on the role of PARP inhibition in the treatment of prostate cancer
Celestia S. Higano, MD, FACP
Charles J. Ryan, MD
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: August 10, 2020
Expired: August 9, 2021
Gain key clinical insights fast, with this short slideset from CCO on biomarkers for imuno-onolcogy approaches across solid tumors
Jamie E. Chaft, MD
John L. Marshall, MD
Scot Niglio, MD
Released: July 15, 2020
Gain key clinical insights fast, with this short slideset from CCO on PARP inhibitor therapy for the treatment of patients with DNA repair–deficient prostate cancer.
Celestia S. Higano, MD, FACP
Charles J. Ryan, MD
Released: July 14, 2020
In this commentary from Clinical Care Options (CCO), Alexander Drilon, MD, discusses best practices in the use of TRK inhibitor therapy
Alexander Drilon, MD
Released: July 10, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.